These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20727892)

  • 41. Effect of comedication with proton pump inhibitors (PPIs) on post-interventional residual platelet aggregation in patients undergoing coronary stenting treated by dual antiplatelet therapy.
    Zuern CS; Geisler T; Lutilsky N; Winter S; Schwab M; Gawaz M
    Thromb Res; 2010 Feb; 125(2):e51-4. PubMed ID: 19781742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Long-term proton pump inhibitor therapy and osteoporosis. Is there a real danger?].
    Maléth J; Hegyi P
    Orv Hetil; 2013 Jun; 154(26):1005-9. PubMed ID: 23800385
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proton pump inhibitors and severe hypomagnesaemia.
    Cundy T; Mackay J
    Curr Opin Gastroenterol; 2011 Mar; 27(2):180-5. PubMed ID: 20856115
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clopidogrel and proton pump inhibitor use: what does the evidence really say?
    Baker WL; Coleman CI; Lundbye JB
    Conn Med; 2010 Jan; 74(1):27-31. PubMed ID: 20175370
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel.
    Small DS; Farid NA; Payne CD; Weerakkody GJ; Li YG; Brandt JT; Salazar DE; Winters KJ
    J Clin Pharmacol; 2008 Apr; 48(4):475-84. PubMed ID: 18303127
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Indications and safety of proton pump inhibitor drug use in patients with cancer.
    Triadafilopoulos G; Roorda AK; Akiyama J
    Expert Opin Drug Saf; 2013 Sep; 12(5):659-72. PubMed ID: 23647006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proton pump inhibitors and bone fractures?
    Laine L
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S21-6. PubMed ID: 19262543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proton pump inhibitors--uncommon adverse effects.
    Oh S
    Aust Fam Physician; 2011 Sep; 40(9):705-8. PubMed ID: 21894279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proton pump inhibitor-induced rhabdomyolysis and hyponatremic delirium.
    Bebarta VS; King JA; McDonough M
    Am J Emerg Med; 2008 May; 26(4):519.e1-2. PubMed ID: 18410837
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proton pump inhibitors: Risks of long-term use.
    Eusebi LH; Rabitti S; Artesiani ML; Gelli D; Montagnani M; Zagari RM; Bazzoli F
    J Gastroenterol Hepatol; 2017 Jul; 32(7):1295-1302. PubMed ID: 28092694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clopidogrel and proton pump inhibitors--boon or bane?].
    Labenz J; Meyners W; Petersen KU
    Dtsch Med Wochenschr; 2010 Feb; 135(5):203-6. PubMed ID: 20104441
    [No Abstract]   [Full Text] [Related]  

  • 52. Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome.
    Singh A; Cresci GA; Kirby DF
    Nutr Clin Pract; 2018 Oct; 33(5):614-624. PubMed ID: 30071147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential Cardiovascular Risks of Proton Pump Inhibitors in the General Population.
    Zhu W; Hong K
    Int Heart J; 2017 Apr; 58(2):163-166. PubMed ID: 28321021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Proton pump inhibitors: not as safe as they seem].
    van Herwaarden N; Bos JM; Veldman B; Kramers C
    Ned Tijdschr Geneeskd; 2016; 160():D487. PubMed ID: 27438396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nutritional consequences of long-term acid suppression; are they clinically important?
    Johnson DA
    Curr Opin Gastroenterol; 2016 Mar; 32(2):136-40. PubMed ID: 26760397
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypomagnesemia and proton pump inhibitors: below the tip of the iceberg.
    Furlanetto TW; Faulhaber GA
    Arch Intern Med; 2011 Aug; 171(15):1391-2. PubMed ID: 21555654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [What is the REAL long-term risk of proton pump inhibitors?].
    Ribiere S; Guillaumot MA; Barré A; Abou Ali E; Barret M; Chaussade S; Coriat R
    Presse Med; 2019 May; 48(5):503-510. PubMed ID: 30926204
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adverse Events of Proton Pump Inhibitors: Potential Mechanisms.
    Corsonello A; Lattanzio F; Bustacchini S; Garasto S; Cozza A; Schepisi R; Lenci F; Luciani F; Maggio MG; Ticinesi A; Butto V; Tagliaferri S; Corica F
    Curr Drug Metab; 2018; 19(2):142-154. PubMed ID: 29219052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of proton pump inhibitors on magnesium balance: is there a link to cardiovascular risk?
    Pisani LF; Filippi E; Vavassori S; Munizio N; Vecchi M; Pastorelli L
    Magnes Res; 2016 Mar; 29(1):1-10. PubMed ID: 27086964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Could magnesium depletion play a role on fracture risk in PPI users?
    Faulhaber GA; Furlanetto TW
    Arch Intern Med; 2010 Oct; 170(19):1776. PubMed ID: 20975030
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.